Several studies have demonstrated the secretion of acetylcholinesterase (AChE) from neurones within the mammalian central nervous system,' which may account for its presence in human cerebrospinal fluid (CSF)' and in amniotic fluid in cases of neural tube defect. 6 Indeed, animal studies have demonstrated increased levels of AChE in CSF following electrical and drug stimulation of the brain.7'9 The release of AChE has also been demonstrated in the peripheral nervous system, for example from the phrenic nerve-diaphragm preparations sympathetic ganglia," and nerve plexuses of the ileum.'2 The last may explain its presence in human amniotic fluid in cases of fetal exomphalos."I Appreciable levels of AChE are present in ocular tissues such as the amacrine cells of the retina'4 and the nerve plexuses of the iris. '5 Hence any secretion of AChE from such tissues would be expected to result in detectable levels of enzymatic activity in the fluids of the eye by analogy with the situation in CSF. Although there are some reports from the 1940s of cholinesterase activity in ocular fluids of various mamalian species,'6 no attempt was made to distinguish between AChE and butyrylcholinesterase (BuChE) activities. Furthermore no attempts have been made to confirm these reports by spectrophotometric assay methods.
In an attempt to demonstrate the possible secretion of AChE from neuronal structures within the human eye we have therefore examined human ocular fluids for the presence of AChE and BuChE activities. We have also compared, by polyacrylamide gel electrophoresis, the enzyme forms present with that present in human CSF, which is thought to derive, by secretion, from neuronal structures of the central nervous system.
Materials and methods

COLLECTION OF OCULAR FLUIDS
At necropsy Ocular fluids were collected at necropsy from persons dying of non-neurological conditions and in whom a past history of eye disease was absent. The eyelids were retracted by hand, and aqueous humour was collected from the anterior chamber by direct puncture through the cornea with a 25 G needle attached to a sterile 1 ml syringe followed by gentle aspiration of the contents. Similarly the vitreous humour was collected from the vitreous cavity by direct puncture through the sclera, posterior to the ciliary body (through pars plana), with a 27 G needle attached to a sterile 2 ml syringe. Any samples in which there was discolouration of the fluid suggesting possible contamination by either iris or retina were discarded. The normal cosmetic appearance of the eye was reconstituted by injecting a similar volume of saline back into the eye chambers.
The ocular fluids were transferred from the syringe to 1 5 ml microfuge tubes and centrifuged for 10 minutes at 12 000 g to sediment particulate matter. The supernatant was then gently aspirated off into another microfuge tube, labelled, snap frozen in liquid nitrogen, and stored at -700C.
Initially, in order to provide adequate volumes for repeated assays, the vitreous and aqueous humours from one patient were pooled (to give a ratio vitreous:aqueous of 10:1). In later experiments the two types of humour were handled separately.
During eye surgery Aqueous humours were collected during eye surgery (for cataract removal) from patients with no history of other eye diseases or neurological disease. The skin of the eyelids was prepared for surgery with iodine solution, then dried. The lids were then held open with a speculum and an initial corneal groove made with a diamond knife. A 27 G sterile needle was passed into the anterior chamber via the corneal groove and approximately 0 1-0-15 ml of aqueous humour removed into a 1 ml syringe. This was transferred straight into a sterile microfuge tube and frozen at -200C within 1 hour.
In six of the patients the surgical procedures were carried out under local anaesthesia (xylocaine), and samples were taken within 10 minutes of retrobulbar injection. The remainder received a general anaesthetic, samples being taken 10-15 minutes after induction of anaesthesia. All patients received premedication consisting of phenylephrine and cyclopentolate eyedrops.
COLLECTION OF CEREBROSPINAL FLUID AT NECROPSY
After opening of the cranial cavity CSF was aspirated from the level of the basal cistern with the exposed brain still in situ. The CSF samples were then centrifuged at 3000 g for 30 minutes at 4VC, and the supernatent was divided into aliquots, snap frozen, and stored at -700C for up to one year. Figure I Graphs to show the relationship between AChE activity ofocularfluid obtained at necropsy and (A) the delay between death and necropsy, (B) the age ofthe patient at death. In each case the line shown is the line ofbestfit as determined by linear regression using the method ofleast squares. Spearman rank correlation coefficients indicated that there was no significant correlation between AChE activity and post-mortem delay, but AChE activity was significantly correlated with age. than that of aqueous humour from the same eye (Table 1) . There was no significant correlation between AChE activity of the total ocular fluid obtained at necropsy and the delay between death and necropsy, the Spearman rank correlation coefficient being 0X181 (n= 17) (Fig IA) . However, there was a significant correlation (p<001) between AChE activity of total ocular fluid and the age of the patient at death, with a Spearman rank correlation coefficient of 0 542 (n= 16) ( Fig  IB) .
Polyacrylamide gel electrophoresis of total ocular fluid revealed one band of AChE activity with a similar mobility to that of AChE in CSF obtained from the cisterna magna of the same patient. Indeed, only one band of AChE activity could be detected in a mixture of ocular fluid and CSF (Fig 2) .
Comparison of the cholinesterase activities of total ocular fluid and cisternal CSF obtained at necropsy indicates that ocular fluid contains slightly higher levels of AChE activity, but considerably lower levels of BuChE activity, than cisternal CSF ( Table 2 ). The specific activity of AChE in ocular fluid was markedly higher than that of cisternal CSF owing to the much lower levels of protein present (Table 2) .
Discussion
These results show that AChE is present in human ocular fluids in appreciable levels while An alternative explanation for higher levels of AChE observed at necropsy is that they are a post-mortem artefact due to the non-specific release of AChE from the tissues of the eye during the period between death and collection at necropsy. However, if this were the case, the level of AChE activity present in the fluid samples should correlate with the time delay between death and necropsy. As these two parameters were not correlated this explanation is unlikely.
The drug regimens of the patients could also contribute to these differences in AChE activity, since various drugs have been shown to affect the secretion of AChE from the central nervous system into CSF.8 Certainly all the surgical patients received the muscarinic antagonist cyclopentolate topically during premedication, and such drugs have been shown to decrease the secretion of AChE into CSF' and from the hippocampus.2 It is therefore possible that this drug also decreases secretion of AChE from cholinergic tissues of the eye such as lens, ciliary body, and iris, and therefore causes lower levels of AChE in the aqueous humour.
The AChE activity of total ocular fluid obtained at necropsy was found to increase with the age of the patient, such that the two were significantly correlated. Previous studies have found a similar effect of age on the AChE activity of CSF.21 22 Polyacrylamide gel electrophoresis indicates that the AChE present in ocular fluid has a similar mobility to that of human CSF; indeed the two activities comigrate in a mixture of the two fluids. The 
